CXCR4 Antagonists: A New Generation of Configurationally Restricted Bis-azamacrocyclic Compounds

Abid Khan; Gary Nicholson; Graeme McRobbie; John Greenman; Christophe Pannecouque; Dirk Daelemans; Dominique Schols; De Clercq Erik; Timothy J. Hubin; Stephen J. Archibald

doi:10.1016/j.antiviral.2009.02.141

Related publications

Article2006

Configurationally Restricted Bismacrocyclic CXCR4 Receptor Antagonists

Gina C. Valks, Graeme McRobbie, Elizabeth A. Lewis, Timothy J. Hubin, T.M. Hunter, Peter J. Sadler, Christophe Pannecouque, De Clercq Erik, Stephen J. Archibald

Article2007

Probing key coordination interactions: configurationally restricted metal activated CXCR4 antagonists

Graeme McRobbie, Gina C. Valks, Christopher J. Empson, Abid Khan, J.D. Silversides, Christophe Pannecouque, De Clercq Erik, Steven G. Fiddy, Adam J. Bridgeman, Nigel A. Young, Stephen J. Archibald

Article2012

CXCR4 chemokine receptor antagonists: nickel(ii) complexes of configurationally restricted macrocycles

Rachel Smith, Dana Huskens, Dirk Daelemans, Ryan E. Mewis, Courtney D. Garcia, Amy N. Cain, TaRynn N. Carder Freeman, Christophe Pannecouque, De Clercq Erik, Dominique Schols, Timothy J. Hubin, Stephen J. Archibald

Article2003

Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists

Mercedes Armand‐Ugón, Miguel E. Quiñones‐Mateu, Arantxa Gutiérrez, Jordi Barretina, Julià Blanco, Dominique Schols, De Clercq Erik, Bonaventura Clotet, José A. Esté

Article2001

Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.

De Clercq Erik, Dominique Schols